Moonshot AI’s Kimi K3 reportedly found Redis flaws and built RCE exploits, raising urgent patching and AI security concerns.

Chinese AI models now lead U.S. business usage on OpenRouter, creating cost advantages for companies and a difficult policy challenge for Washington.

Unitree has unveiled UnifoLM-OminiA-0.3, a unified embodied AI model designed to help humanoid robots perform household and care-related tasks.

Chinese AI models are gaining business interest as companies weigh lower costs, open-weight flexibility, performance trade-offs, and enterprise risks.

China’s new AI companion rules restrict emotional dependency, require crisis protections, and impose safeguards for children and user data.

Hyundai workers in South Korea strike over pay and job protections as the automaker plans to deploy Atlas humanoid robots across Hyundai and Kia factories.

Nvidia is partnering with Japan’s robotics leaders to develop smarter factories using physical AI, new models, and domestic computing infrastructure.

Xiaomi says its humanoid robot achieved a 98% success rate on a task at an EV factory, narrowing the gap with human operators.

Apple has reportedly secured approval to launch Apple Intelligence in China with help from Alibaba and Baidu, raising new geopolitical questions.

US regulators cleared ZTE and Maginfra to buy Nvidia H200 chips, while a Kingsoft Cloud subsidiary received approval for AMD chips.

China unveiled measures to embed AI across consumer products, services, retail, logistics, and elderly care as it pushes nationwide AI adoption.

Independent advisors for the Food and Drug Administration on Friday voted 9–0 in support of approving Moderna's seasonal mRNA flu vaccine, which a Trump appointee at the agency initially tried to block from even being reviewed.

In an all-day meeting, members of the FDA's advisory committee—known as VRBPAC for Vaccines and Related Biological Products Advisory Committee—pored over data and presentations on the vaccine, which is dubbed mRNA-1010 and branded as mFlusiva. The presentations included a review from FDA scientists, which was supportive of the vaccine.

Data from a Phase 3 trial including over 40,000 adults age 50 and older found the mRNA vaccine was around 27 percent more effective against seasonal flu than a standard flu shot. A smaller Phase 3 trial, involving data from nearly 3,000 people age 65 years and older, showed the shot produces stronger immune responses than a high-dose flu vaccine, which is recommended for this age group. The safety profile of the vaccine was also generally good.

Read full article

Comments

© DeFodi Images

FIFA and Hyundai are using Boston Dynamics Spot robots for patrols, inspections, and risk detection at select 2026 World Cup venues.

Guardrails positions itself as a populist political movement that runs on small donations from people in the trenches of the AI boom.

Hong Kong plans a 24-hour convenience store run by Galbot’s Xiao Gai humanoid robot, bringing embodied AI into public retail and customer service.

Humanoid robots joined human models on a Seoul runway, highlighting how robotics is moving into fashion, entertainment, and public culture.

China’s robot schools are training humanoids through repetition, VR-guided demonstrations, and shared data to prepare them for real-world work.

Alibaba launched Qwen Robot Suite, its first suite of AI models designed to help robots navigate, manipulate objects, and predict physical outcomes.

Quantum Space says SPACs aren't dead as it seeks a $1.2 billion deal to build military spacecraft.

Neura Robotics raised up to $1.4 billion as the German startup tries to scale humanoid robots and physical AI against China and US rivals.